Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Neomycin × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Paclitaxel 243 Cisplatin 218 Gemcitabine 213 Carboplatin 207 Cyclophosphamide 188 Radiotherapy 180 Irinotecan 151 Docetaxel 144 pembrolizumab 142 Bevacizumab 141 Capecitabine 123 Nivolumab 116 Fluorouracil 107 Dexamethasone 107 Erlotinib Hydrochloride 103 Bortezomib 101 Sorafenib 98 Oxaliplatin 97 Cytarabine 97 Filgrastim 93 Temozolomide 92 Doxorubicin 90 Etoposide 88 Leucovorin 87 Rituximab 85 Lenalidomide 82 Everolimus 81 Pemetrexed 74 Ipilimumab 73 Topotecan 71

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02001909 2015-08-13

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Bayer

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡